CNE000000Q45
CNE000000Q45
APELOA PHARMA.
Loading chart...
Valuation & History
Quarterly trend of key valuation metrics
| Metric | Current (TTM) TTM Baseline | Q2 '26 30.06.2026 | Q1 '26 31.03.2026 | Q4 '25 31.12.2025 |
|---|---|---|---|---|
Market & Enterprise Value | ||||
Market Cap | 29.42B EUR | 19.3B EUR | 20.66B EUR | 18.85B EUR |
Enterprise Value | 27.07B EUR | 17.79B EUR | 18.63B EUR | 16.62B EUR |
Valuation Multiples | ||||
Trailing P/E | 34.32x | 27.08x | 27.4x | 25.02x |
Forward P/E | 24.66x | -- | -- | -- |
Price to Sales | 3.21x | 2.82x | 2.88x | 2.53x |
Price to Book | 4.35x | 2.94x | 3.15x | 2.97x |
EV/Revenue | 2.96x | 2.6x | 2.59x | 2.23x |
EV/EBITDA | 16.94x | 15.31x | 15.57x | 19.24x |
Price to FCF (P/FCF) | -- | 154.74x | 30.5x | 36.18x |
EV/FCF | -- | 142.63x | 27.5x | 31.9x |
FCF Yield | -0.22% | 0.65% | 3.28% | 2.76% |